Pacira Biosciences
PCRX
#5836
Rank
โ‚น96.83 B
Marketcap
โ‚น2,155
Share price
0.04%
Change (1 day)
32.10%
Change (1 year)
Categories

Revenue for Pacira Biosciences (PCRX)

Revenue in 2025 (TTM): โ‚น61.97 Billion

According to Pacira Biosciences 's latest financial reports the company's current revenue (TTM ) is โ‚น64.39 Billion. In 2024 the company made a revenue of โ‚น60.13 Billion an increase over the revenue in the year 2023 that were of โ‚น56.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacira Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น61.97 B3.06%
2024 โ‚น60.13 B7.02%
2023 โ‚น56.19 B1.83%
2022 โ‚น55.17 B36.9%
2021 โ‚น40.30 B28.28%
2020 โ‚น31.42 B4.66%
2019 โ‚น30.02 B27.31%
2018 โ‚น23.58 B28.86%
2017 โ‚น18.30 B-2.55%
2016 โ‚น18.78 B13.5%
2015 โ‚น16.54 B32.08%
2014 โ‚น12.52 B137.03%
2013 โ‚น5.28 B146.99%
2012 โ‚น2.13 B157.86%
2011 โ‚น0.82 B27.18%
2010 โ‚น0.65 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Recro Pharma
REPH
โ‚น6.77 B-89.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚น9.01 B-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
โ‚น0.64 B-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
โ‚น13.93 B-78.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚น7.33 B-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA